SCHEMBL25947154

SCHEMBL25947154

c1ccc(-c2ccc(-c3ccc(-c4ccc(-c5nc(-c6ccc7c(c6)oc6ccccc67)nc(-c6cccc7c6sc6ccccc67)n5)cc4)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 8/20 0.45
ALOX5 P09917 2/20 0.43
PIK3CD O00329 2/20 0.36
PIK3CB P42338 2/20 0.36
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
BRD4 O60885 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
KCNH2 Q12809 1/20 0.34
BRDT Q58F21 1/20 0.34
AHR P35869 1/20 0.34
PARP14 Q460N5 1/20 0.34
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645948 1.00 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBMMP12
SCHEMBL21890983 0.99 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL26080584 0.98 PRKDC (0.43) PRKDCALOX5PIK3CDPIK3CBMMP12
SCHEMBL24318138 0.97 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL26080826 0.97 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBMMP12
SCHEMBL22135492 0.97 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL25645949 0.97 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBMMP12
SCHEMBL25627231 0.97 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL25627227 0.97 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL23024891 0.96 PRKDC (0.42) PRKDCALOX5PIK3CDPIK3CBMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4212526-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PRKDC 4577/4885ALOX5 579/4885PIK3CD 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.